Phase II Trial for Stage III and IVa Head and Neck Cancer
Joel Tepper, M.D. and colleagues have published an article entitled Phase II Trial of Hyperfractionated Intensity-Modulated Radiation Therapy and Concurrent Weekly Cisplatin for Stage III and IVa Head-and-Neck Cancer published in the March 15, 2011 issue of the International Journal of Radiation Oncology•Biology•Physics (Volume 79, Number 4).